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Introduction
Acute low-tone sensorineural hearing loss (ALHL) was 
initially considered as a variant of idiopathic sudden sensori-
neural hearing loss [1] until its first description as an inde-
pendent disease entity by Abe in 1982 [2]. Although the au-
diometric definition of ALHL is not yet fully established, 
one of the most widely applied diagnostic criteria was pro-
posed by the Study Group for Acute Profound Deafness Re-
search Committee of the Ministry of Health, Labor, and Wel-
fare of Japan. It defines ALHL as acute onset of hearing loss 
with the sum of hearing levels in affected ears at low fre-
quencies of 125, 250, and 500 Hz as 70 dB or more, and the 
sum of hearing levels at high frequencies of 2, 4, and 8 kHz 
as 60 dB or less. The pathophysiology of ALHL is yet un-
known but is suggested to be similar to idiopathic sudden 
deafness [3]. It has been associated with cochlear hydrops or 
early stage Meniere’s disease [3-5]. Steroids or mild diuretics 
have been used for clinical treatment, and the prognosis in the 
short-term has been reported to be better than sudden hearing 
loss [2]. However, recurrence of hearing loss and possible pro-
gression to Meniere’s disease remain important concerns in 
the clinical setting [4,6,7]. In a previous report, the rate of re-
currence was about 40% [8], and the rate of progression to 
Meniere’s disease was about 11% [4]. 
This study aims to examine the clinical course of ALHL 
patients during long-term follow-up of more than 3 months 
and to identify associated factors.
Subjects and Methods
We retrospectively reviewed the medical records of 105 pa-
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Background and Objectives: Although acute low-tone hearing loss has been associated 
with cochlear hydrops or early stage Meniere’s disease, its prognosis in the short-term has 
been reported to be better than sudden hearing loss. However, recurrence of hearing loss and 
possible progression to Meniere’s disease remain important concerns in the clinical setting. 
This study aims to investigate the long-term audiological outcomes of acute low-tone hearing 
loss. Subjects and Methods: A retrospective review of patients presenting with a first attack 
of acute low-tone hearing loss was performed. Of the 77 patients, 33 were followed up for 
more than 3 months. Progression, recovery of hearing loss and recurrence of hearing loss 
were examined. Also, correlation between long-term outcomes and associated clinical fac-
tors were analyzed. Results: Twenty-five patients (75.7%) had complete hearing recovery, 
five patients (15.1%) had partial recovery, two patients (6.0%) had no recovery, and one pa-
tient (3.0%) had progression of hearing loss 1 month after initial treatment. Thirty-three pa-
tients were followed up for more than 3 months (mean 22 months, range 3-79 months). Re-
currences of acute low-tone hearing loss were observed in five patients (15.2%). All of the 
recurrences occurred during the first 12 months of follow-up. Long-term prognosis correlat-
ed with the initial therapy results (R2=0.693). Conclusions: Recurrences of hearing loss 
were documented in five patients (15.2%), and all of these cases occurred within one year 
of the first attack. Audiological outcomes after initial therapy may predict the recurrence of 
acute low-tone hearing loss. J Audiol Otol 2015;19(2):74-78
KEY WORDS: Acute low-tone hearing loss · Prognosis · Hearing loss.
This is an Open Access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/3.0/) which permits unrestricted non-commercial 
use, distribution, and reproduction in any medium, provided the original 
work is properly cited.
online © ML Comm
www.ejao.org 75
Roh KJ, et al.
Results
Table 1 summarizes the clinical characteristics of 33 patients 
with ALHL who were followed up for more than 3 months. M:F 
ratio was 13:20, and mean age was 41 years (range 14-69 
years). Hearing loss was in the left ear in 20 patients and the 
right ear in 13. Mean follow-up period was 22 months (range 
3-79 months).
Hearing thresholds were measured at initial presentation 
(Fig. 1). The hearing thresholds (mean±SD) in the affected 
ear at each frequency were: 49±43 dB HL at 250 Hz; 45±
17 dB HL at 500 Hz; 33±21 dB HL at 1 kHz; 23±16 dB 
HL at 2 kHz; 22±14 dB HL at 4 kHz; and 27±17 dB HL at 
8 kHz. In the opposite ear, the hearing thresholds (mean±
SD) at each frequency were: 11±7 dB HL at 250 Hz; 10±7 
dB HL at 500 Hz; 12±8 dB HL at 1 kHz; 17±22 dB HL at 
Table 1. Summary of clinical characteristics
Total (n=33)
Age
Avg±SD (yrs) 41±12.68
Range (yrs) 14-69
Gender (M:F) 13:20
Laterality (R:L) 13:20
F/u period
Avg±SD (months) 22±21.23
Range (months) 3-79
Recurrence 5 (15.2%)
M: male, F: female, R: right, L: left, SD: standard deviation, F/u: 
followed up, Avg: average, yrs: years
tients presenting with a first attack of acute low-tone hearing 
loss in the Department of Otorhinolaryngology of Yonsei 
University Gangnam Severance Hospital from January 2007 
to January 2013. ALHL was defined by the following crite-
ria: an acute onset sensorineural hearing loss at low frequen-
cies (250 and 500 Hz); a sum of hearing levels at low fre-
quencies ≥50 dB; and a hearing threshold difference between 
both ears <10 dB at high frequencies (2 and 4 kHz). Patients 
who presented after more than 2 weeks from onset of symp-
toms were excluded. Patients with the following criteria were 
also excluded: 1) evidence of sound conduction deficit; 2) bi-
lateral involvement; 3) history of episodic vertigo or presence 
of nystagmus at initial visit; and 4) neurological abnormalities 
on history review or physical examination. The remaining 77 
patients were included in our study. Of the 77 patients, 33 
were followed up for more than 3 months. The patients were 
routinely examined by pure tone average. Treatment modali-
ties included systemic oral corticosteroids and/or diuretics 
and/or intratympanic dexamethasone injection. Corticoste-
roid treatment consisted of 30-60 mg methylprednisolone 
per day as a starting dose administered orally and tapering for 
10 days. Diuretic treatment consisted of a daily oral 50 mg 
spironolactone for 2 weeks. Intratympanic injections of 0.5 
cc dexamethasone (5 mg/mL) for 5 days were performed. At 
1 month after the first visit, the results of initial therapy 
were evaluated according to the following criteria: complete 
recovery if hearing thresholds at low frequencies were less 
than 20 dB or the same level as the opposite ear; partial re-
covery if the average of hearing thresholds at low frequen-
cies improved more than 10 dB but was not at the same lev-
el as the opposite ear; unchanged (UC) if the average hearing 
thresholds at low frequencies improved <10 dB; and pro-
gressive changes for patients with hearing changes other than 
those in the aforementioned three categories [9]. Hearing 
evaluations were performed at regular intervals: at initial vis-
it, after one month, then at 3- or 6-month intervals. The pro-
gression or recovery of hearing loss and recurrence of hear-
ing loss were examined, and correlation between long-term 
outcomes and associated clinical factors were analyzed.
Statistical analysis
All statistics were calculated with SPSS v20.0 for Windows 
(SPSS Inc., Chicago, IL, USA). p-value<0.05 was considered 
statistically significant. Statistical evaluation regarding cor-
relation between various intervals was performed using bi-
variate correlation analysis. The analysis of recurrence-free 
rate was performed using Kaplan-Meier test. Fig. 1. Pure tone average at various intervals. Median air conduc-
tion thresholds in both ears (affected and opposite) at initial presen-
tation, in affected ears at 1 month, and in affected ears at the last 
f/u visit. f/u: followed up.
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tion between audiological outcomes at various intervals (Fig. 
3). Although there was no significant correlation between the 
dB-sum of the affected ears at initial presentation and last 
follow-up (Fig. 3A), a positive linear correlation was ob-
served between the dB-sum at 1 month and last follow-up 
(Fig. 3B) (R2=0.693). The results suggest that the long-term 
audiological outcomes show better correlation with the hear-
ing thresholds at 1 month after initial treatment than with the 
initial hearing levels. Recurrence of acute low-tone hearing 
loss was observed in five patients (15.2%). All of the recur-
rences occurred during the first year of follow-up. Three pa-
tients presented with recurred hearing loss within 3 months, 
and two patients between 3 months and one year (Fig. 4).
2 kHz; 17±15 dB HL at 4 kHz; and 23±20 dB HL at 8 kHz. 
Affected ear audiogram at initial visit shows an ascending 
typed graph, and at high frequencies, the difference in thresh-
old between the affected ear and the opposite ear was less 
than 10 dB. According to audiograms after 1 month and at last 
examination, the recovery of hearing loss at low frequencies 
occurred mostly in the first month. 
After initial treatment at 1 month, 25 patients (75.7%) had 
complete hearing recovery, five patients (15.1%) had partial 
recovery, two patients (6.0%) had no recovery, and one pa-
tient (3.0%) had progression of hearing loss (Fig. 2). The re-
sults of hearing level at the last follow-up showed a few im-
provements compared to 1 month after initial visit, but the 
changes were not statistically significant. At the last follow-
up, 29 patients (87.8%) had complete hearing recovery, three 
patients (9.0%) had partial recovery, and one patient (3.0%) 
had no recovery. We calculated the decibel-sum (dB-sum) of 
hearing thresholds at 250 and 500 Hz to analyze the correla-
Fig. 2. Analysis of recovery outcomes. After initial treatment at 1 
month, 25 patients (75.7%) had complete hearing recovery, five 
patients (15.1%) had PR, two patients (6.0%) had no recovery, 
and one patient (3.0%) had progression of hearing loss. At the last 
f/u, 29 patients (87.8%) had complete hearing recovery, three pa-
tients (9.0%) had PR, and one patient (3.0%) had no recovery. 
CR: complete recovery, PR: partial recovery, UC: unchanged, PC: 
progressive change, f/u: follow-up.
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Fig. 3. Low-tone dB-sum of hearing 
thresholds at 250 and 500 Hz cor-
relation analysis. A: Correlation be-
tween initial presentation and last 
follow-up. B: Correlation between 
1-month visit and last follow-up.
Fig. 4. Kaplan-Meier plots of 33 patients with ALHL indicating the 
rate and timing of recurrence of symptoms during follow-up. Re-
currence of ALHL was observed in five patients (15.2%). All of the 
patients with recurrence experienced it within 1 year of the first 
episode of hearing loss. ALHL: acute low-tone sensorineural 
hearing loss, yr: year.
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Discussion
ALHL is known to have a relatively good prognosis and 
generally improves within a short time after treatment [10]. 
However, fluctuation of hearing loss or progression to overt 
Meniere’s disease has been reported [6]. Few reports are 
available about the long-term outcomes of ALHL. Oishi, et 
al. [11] reported that about half of the cases in their study de-
veloped high- or pan- frequency hearing loss within 10 years 
of onset of low-frequency hearing loss. They also reported 
that the initial therapy results and fluctuation of hearing dur-
ing the first year may indicate the long-term prognosis of pa-
tients presenting with low-frequency hearing loss. In our 
study, the audiological outcomes of ALHL patients were ex-
amined for more than 3 months. Our findings indicate that in 
most patients, the hearing levels were improved within 1 
month after initial treatment with steroids and/or diuretics, in 
accordance with other studies. A previous report by Oishi, et 
al. [11] indicated that hearing fluctuation during the first year 
after the initial attack correlated with the 10-year prognosis of 
ALHL (r=0.43). Considering that recurrence of hearing loss 
was documented in five patients (15.2%) within our one-year 
period, longer follow-up of these cases would be needed. 
Predictive factors of ALHL have been investigated. Ya-
masoba, et al. [4] reported that ratios of the summating poten-
tial to the action potential (SP/AP ratios) were abnormally in-
creased in electrocochleography (ECoG) in most patients with 
ALHL. In the study of Fushiki, et al. [8], patients with an ele-
vated SP/AP ratio and spontaneous nystagmus on electronys-
tagmography had a recurrence rate of approximately 80% after 
long-term follow-up. The study demonstrated that a combina-
tion of nystagmus detection and ECoG testing could improve 
the accuracy of both prognosis and treatment planning in pa-
tients with sudden low-tone sensorineural hearing loss without 
vertigo [8]. These findings support the possibility that ALHL 
overlaps with an early stage of Meniere’s disease or endolym-
phatic hydrops of the cochlea. In addition, Hong, et al. [12] 
reported that cochlear hydrops analysis masking procedure 
(CHAMP) measurement may be useful for determining the 
prognosis of patients with ALHL without vertigo. They ob-
served that patients with an abnormal complex amplitude ratio 
on CHAMP had a 2.6-fold increased risk of progression to a 
clinical spectrum of endolymphatic hydrops. Although we 
could not determine the correlations between various audio-
vestibular examinations and hearing outcomes due to a rela-
tively small number of cases, our findings suggest that hear-
ing levels after initial treatment may predict the long-term 
audiological outcomes in ALHL. 
One of the limitations of our study is that only 33 of total 77 
patients were followed up for more than 3 months. When we 
included the patients who were lost to follow-up in the initial 
treatment outcome analysis, UC group increased from 6 to 
16%. The patients were likely unsatisfied with the initial treat-
ment outcome and showed higher dropout rate. Our results 
should be interpreted with caution to this selection bias, and 
further study about ALHL patients need to be followed through 
a prospective study with fewer dropouts.
To our knowledge, there is no report that correlates the prog-
nosis of ALHL with severity of initial hearing loss. In our 
study, hearing recovery was not correlated with severity at 
initial presentation, but with the initial treatment outcome at 1 
month. Since, most of ALHL patients present with mild to 
moderate hearing loss restricted in the low frequencies, further 
studies of larger groups of patients are warranted to investigate 
the correlation.
Conclusion
Our results suggest that the hearing levels after initial 
treatment correlate with long-term outcomes in ALHL. Also, 
recurrence of hearing loss generally occurred during the first 
year after initial presentation, suggesting the importance of 
longer follow-up for ALHL patients.
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